Service interruption on Monday 11 July from 12:30 to 13:00: all the sites of the CCSD (HAL, Epiciences, SciencesConf, AureHAL) will be inaccessible (network hardware connection).
Skip to Main content Skip to Navigation
Journal articles

IL-15 as a potential target in leukemia

Abstract : Leukemia, one of the most aggressive hematopoietic malignancies, is characterized by excessive proliferation, survival, and impaired differentiation of hematopoietic stem cells. Interleukin 15, a proinflammatory cytokine, induces proliferation and promotes cell survival of human T and B lymphocytes, as well as natural killer cells. However, it may also play a detrimental role in the onset of leukemia. This review provided an overview of the aberrant expression of Interleukin 15 and its role in the development and progression of this hematological malignancy. Also, we critically explored the potential therapeutic opportunities involved in targeting the disruption of interleukin-15 signaling as well as in interleukin-15-mediated enhancement of antitumor immunity.
Complete list of metadata

Cited literature [87 references]  Display  Hide  Download
Contributor : Imopa UL Connect in order to contact the contributor
Submitted on : Friday, February 10, 2017 - 11:43:33 AM
Last modification on : Monday, April 4, 2022 - 10:24:36 AM
Long-term archiving on: : Thursday, May 11, 2017 - 1:04:40 PM


Publisher files allowed on an open archive




yu Xiong, Danièle Bensoussan, Véronique Decot. IL-15 as a potential target in leukemia. Blood and lymphatic cancer: targets and therapy, Dove Medical Press, 2015, 5, pp.55—63. ⟨10.2147/BLCTT.S78347⟩. ⟨hal-01464505⟩



Record views


Files downloads